Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Could there be a role for the antidiabetic drug metformin in oncological treatment?
DOI: 10.12892/ejgo4677.2018
World trends of incidence of gynecologic malignancies in young women
DOI: 10.12892/ejgo4234.2018
Surgical staging and differential protein expression in endometrial cancers
DOI: 10.12892/ejgo4669.2018
Robotic radical trachelectomy with sentinel lymph node mapping using ICG in early cervical cancer – a brief report
DOI: 10.12892/ejgo4198.2018
Concentration of serotonin in perimenopausal women with ductal breast cancer and polycystic ovary syndrome
DOI: 10.12892/ejgo4121.2018
Doxorubicin hydrochloride and bevacizumab for the patients with platinum-taxane resistant ovarian cancer
DOI: 10.12892/ejgo4066.2018
Disease profile and incidence of hydatidiform mole in Vitoria (Brazil) between 2003-2016
DOI: 10.12892/ejgo4326.2018
Investigation of paclitaxel-carboplatin one-cycle neoadjuvant chemotherapy plus trastuzumab in HER2-positive breast cancer
DOI: 10.12892/ejgo4533.2018
Poor prognosis associated with venous thromboembolism in Asian patients with ovarian clear cell carcinoma
DOI: 10.12892/ejgo3972.2018
Clinical significance of atypical glandular cells in Pap tests: experience of a gynecologic oncology center in 74 patients
DOI: 10.12892/ejgo3977.2018
Expression analysis of the Beclin-1 in premalignant and malignant tissues of the uterine cervix
DOI: 10.12892/ejgo4028.2018
Correlation between the intrinsic subtype and diagnostic methodsof axillary lymph node metastasis in primary breast cancer
DOI: 10.12892/ejgo4009.2018
The impact of progesterone receptor isoforms expression to invasion capacity and SULT1E1 in endometrial cancer cells
DOI: 10.12892/ejgo4356.2018
“See and treat” LEEP biopsy for cervical intraepithelial neoplasia grade 2/3
DOI: 10.12892/ejgo4391.2018
The TP53 - R72P (rs1042522) polymorphism and risk factors in breast cancer patients
DOI: 10.12892/ejgo4419.2018
Upregulation of ATF3 expression inhibit the proliferation of human uterine serous carcinoma in vitro
DOI: 10.12892/ejgo4507.2018
Increased expression of lncRNA HULC in human epithelial ovarian cancer and its biological functions
DOI: 10.12892/ejgo4239.2018
Long survival metastatic ovarian neoplasm under bevacizumab maintenance strategy
DOI: 10.12892/ejgo4041.2018
Very long response with trastuzumab for metastaticHer2-positive breast cancer
DOI: 10.12892/ejgo4040.2018
Ovarian borderline clear cell adenofibroma in a 42-year-old woman: a case report and a literature review
DOI: 10.12892/ejgo3943.2018
Krukenberg tumor – two diagnostically challenging cases and a brief review
DOI: 10.12892/ejgo4099.2018
Retroperitoneal teratoma misdiagnosed as ovarian tumor: a case report
DOI: 10.12892/ejgo4171.2018
Intrapelvic sclerosing epithelioid fibrosarcoma: a case report
DOI: 10.12892/ejgo4241.2018
Palbociclib + fulvestrant in a positive hormonal receptors metastatic breast cancer
DOI: 10.12892/ejgo4047.2018
Adenoid cystic carcinoma of Bartholin’s gland. From the ISSVD Case Consultation Committee
DOI: 10.12892/ejgo4441.2018